

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.18557596 |
| 2 | locomotory exploration behavior (GO:0035641) | 6.03881844 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.78807588 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.72678658 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.35709296 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.21546764 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.20205889 |
| 8 | * positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.19348621 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.10655273 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.06153624 |
| 11 | regulation of neuronal synaptic plasticity (GO:0048168) | 5.00341222 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.97253004 |
| 13 | * regulation of glutamate receptor signaling pathway (GO:1900449) | 4.82186153 |
| 14 | synaptic vesicle exocytosis (GO:0016079) | 4.82092447 |
| 15 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.79722805 |
| 16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.77492128 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.77492128 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 4.77492128 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.77492128 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.77492128 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.77492128 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.72948874 |
| 23 | regulation of synapse structural plasticity (GO:0051823) | 4.70762837 |
| 24 | vocalization behavior (GO:0071625) | 4.70358000 |
| 25 | glutamate secretion (GO:0014047) | 4.67872476 |
| 26 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.63577668 |
| 27 | exploration behavior (GO:0035640) | 4.62247190 |
| 28 | B cell receptor signaling pathway (GO:0050853) | 4.57731987 |
| 29 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.57347348 |
| 30 | detection of other organism (GO:0098543) | 4.47216086 |
| 31 | detection of bacterium (GO:0016045) | 4.46280446 |
| 32 | * ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.45539358 |
| 33 | regulation of gamma-delta T cell activation (GO:0046643) | 4.45003909 |
| 34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.36069276 |
| 35 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.34068190 |
| 36 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.25103615 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 4.23384006 |
| 38 | long-term memory (GO:0007616) | 4.21350045 |
| 39 | protein localization to synapse (GO:0035418) | 4.14098782 |
| 40 | regulation of synaptic vesicle transport (GO:1902803) | 4.10387952 |
| 41 | negative thymic T cell selection (GO:0045060) | 4.07288280 |
| 42 | synaptic transmission, glutamatergic (GO:0035249) | 4.05367660 |
| 43 | response to peptidoglycan (GO:0032494) | 4.05259372 |
| 44 | neutrophil activation involved in immune response (GO:0002283) | 4.04698890 |
| 45 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.04663903 |
| 46 | * regulation of synaptic plasticity (GO:0048167) | 4.01925395 |
| 47 | positive thymic T cell selection (GO:0045059) | 4.00675197 |
| 48 | immunoglobulin mediated immune response (GO:0016064) | 4.00256202 |
| 49 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.99643970 |
| 50 | negative regulation of cell killing (GO:0031342) | 3.95208172 |
| 51 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.95208172 |
| 52 | positive regulation of B cell differentiation (GO:0045579) | 3.94560616 |
| 53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.92142862 |
| 54 | negative T cell selection (GO:0043383) | 3.89831672 |
| 55 | leukocyte aggregation (GO:0070486) | 3.89197970 |
| 56 | * regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.86466653 |
| 57 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.84145416 |
| 58 | T cell migration (GO:0072678) | 3.81809150 |
| 59 | * glutamate receptor signaling pathway (GO:0007215) | 3.81498525 |
| 60 | neuronal action potential propagation (GO:0019227) | 3.79182166 |
| 61 | response to muramyl dipeptide (GO:0032495) | 3.78011926 |
| 62 | negative regulation of T cell mediated immunity (GO:0002710) | 3.77218835 |
| 63 | response to interleukin-15 (GO:0070672) | 3.75003298 |
| 64 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.70042827 |
| 65 | * regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.69821709 |
| 66 | neuron-neuron synaptic transmission (GO:0007270) | 3.68164476 |
| 67 | neurotransmitter secretion (GO:0007269) | 3.68147492 |
| 68 | regulation of ARF protein signal transduction (GO:0032012) | 3.68044315 |
| 69 | cellular extravasation (GO:0045123) | 3.64986364 |
| 70 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.63886829 |
| 71 | regulation of B cell differentiation (GO:0045577) | 3.61396561 |
| 72 | type I interferon signaling pathway (GO:0060337) | 3.60850384 |
| 73 | cellular response to type I interferon (GO:0071357) | 3.60850384 |
| 74 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.60522675 |
| 75 | response to type I interferon (GO:0034340) | 3.59360198 |
| 76 | negative regulation of interleukin-12 production (GO:0032695) | 3.59166802 |
| 77 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.56246336 |
| 78 | detection of external biotic stimulus (GO:0098581) | 3.56091152 |
| 79 | germinal center formation (GO:0002467) | 3.55508170 |
| 80 | positive regulation of synapse maturation (GO:0090129) | 3.51728703 |
| 81 | * regulation of postsynaptic membrane potential (GO:0060078) | 3.49146822 |
| 82 | thymic T cell selection (GO:0045061) | 3.48864218 |
| 83 | cellular potassium ion homeostasis (GO:0030007) | 3.48559667 |
| 84 | cellular response to interleukin-15 (GO:0071350) | 3.47208326 |
| 85 | dendritic spine morphogenesis (GO:0060997) | 3.45916099 |
| 86 | response to host immune response (GO:0052572) | 3.45136749 |
| 87 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.45136749 |
| 88 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.43058444 |
| 89 | positive regulation of fibroblast migration (GO:0010763) | 3.40782528 |
| 90 | neuromuscular process controlling balance (GO:0050885) | 3.40446266 |
| 91 | myeloid cell activation involved in immune response (GO:0002275) | 3.39678450 |
| 92 | * long-term synaptic potentiation (GO:0060291) | 3.38355535 |
| 93 | T cell selection (GO:0045058) | 3.38267010 |
| 94 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.37434774 |
| 95 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.37219881 |
| 96 | positive T cell selection (GO:0043368) | 3.36092961 |
| 97 | sodium ion export (GO:0071436) | 3.35343839 |
| 98 | behavioral fear response (GO:0001662) | 3.35013493 |
| 99 | behavioral defense response (GO:0002209) | 3.35013493 |
| 100 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.34458167 |
| 101 | regulation of Rap GTPase activity (GO:0032317) | 3.34049272 |
| 102 | regulation of dendritic spine development (GO:0060998) | 3.33469426 |
| 103 | * positive regulation of membrane potential (GO:0045838) | 3.32759979 |
| 104 | activation of protein kinase A activity (GO:0034199) | 3.22116455 |
| 105 | response to histamine (GO:0034776) | 3.22110572 |
| 106 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.21207804 |
| 107 | dendritic spine organization (GO:0097061) | 3.20412698 |
| 108 | defense response to protozoan (GO:0042832) | 3.20142702 |
| 109 | response to host (GO:0075136) | 3.19756830 |
| 110 | response to host defenses (GO:0052200) | 3.19756830 |
| 111 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.19756830 |
| 112 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.16315180 |
| 113 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.15638570 |
| 114 | regulation of mast cell degranulation (GO:0043304) | 3.15563246 |
| 115 | proline transport (GO:0015824) | 3.14328513 |
| 116 | microglial cell activation (GO:0001774) | 3.13569845 |
| 117 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.13188406 |
| 118 | positive regulation of neurotransmitter transport (GO:0051590) | 3.13050889 |
| 119 | regulation of female receptivity (GO:0045924) | 3.11966337 |
| 120 | neutrophil activation (GO:0042119) | 3.11517828 |
| 121 | synaptic vesicle endocytosis (GO:0048488) | 3.10209189 |
| 122 | respiratory burst (GO:0045730) | 3.09776427 |
| 123 | detection of biotic stimulus (GO:0009595) | 3.09514095 |
| 124 | B cell mediated immunity (GO:0019724) | 3.09447779 |
| 125 | positive regulation of dendritic spine development (GO:0060999) | 3.07278336 |
| 126 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.07207101 |
| 127 | response to amphetamine (GO:0001975) | 3.06809466 |
| 128 | chemosensory behavior (GO:0007635) | 3.06301135 |
| 129 | prepulse inhibition (GO:0060134) | 3.05886992 |
| 130 | L-amino acid import (GO:0043092) | 3.05535345 |
| 131 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.05146315 |
| 132 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.04534338 |
| 133 | detection of molecule of bacterial origin (GO:0032490) | 3.03127252 |
| 134 | B cell homeostasis (GO:0001782) | 3.02498556 |
| 135 | regulation of vesicle fusion (GO:0031338) | 3.01587357 |
| 136 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.00650359 |
| 137 | long term synaptic depression (GO:0060292) | 3.00567308 |
| 138 | negative regulation of amino acid transport (GO:0051956) | 3.00512862 |
| 139 | response to protozoan (GO:0001562) | 2.99872016 |
| 140 | mast cell activation (GO:0045576) | 2.99333309 |
| 141 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.99166788 |
| 142 | fear response (GO:0042596) | 2.98160982 |
| 143 | regulation of leukocyte degranulation (GO:0043300) | 2.96469895 |
| 144 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.93472758 |
| 145 | * regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.93135465 |
| 146 | positive regulation of Rap GTPase activity (GO:0032854) | 2.92866998 |
| 147 | learning (GO:0007612) | 2.92602319 |
| 148 | macrophage activation (GO:0042116) | 2.92413843 |
| 149 | leukocyte degranulation (GO:0043299) | 2.91770922 |
| 150 | vesicle transport along microtubule (GO:0047496) | 2.90391264 |
| 151 | * regulation of synaptic transmission (GO:0050804) | 2.90287828 |
| 152 | regulation of glutamate secretion (GO:0014048) | 2.90243539 |
| 153 | * membrane depolarization (GO:0051899) | 2.89843301 |
| 154 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.89563957 |
| 155 | granulocyte activation (GO:0036230) | 2.89419098 |
| 156 | regulation of neurotransmitter secretion (GO:0046928) | 2.88938099 |
| 157 | regulation of antigen processing and presentation (GO:0002577) | 2.87954803 |
| 158 | nerve growth factor signaling pathway (GO:0038180) | 2.87319912 |
| 159 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.86641126 |
| 160 | mast cell activation involved in immune response (GO:0002279) | 2.85883043 |
| 161 | mast cell degranulation (GO:0043303) | 2.85883043 |
| 162 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.84478549 |
| 163 | positive regulation of granulocyte differentiation (GO:0030854) | 2.83785617 |
| 164 | * positive regulation of synaptic transmission (GO:0050806) | 2.82831921 |
| 165 | positive regulation of vesicle fusion (GO:0031340) | 2.82807673 |
| 166 | layer formation in cerebral cortex (GO:0021819) | 2.82748854 |
| 167 | tolerance induction (GO:0002507) | 2.82560734 |
| 168 | positive regulation of mast cell activation (GO:0033005) | 2.81360015 |
| 169 | regulation of T cell tolerance induction (GO:0002664) | 2.80816664 |
| 170 | adenosine receptor signaling pathway (GO:0001973) | 2.80791476 |
| 171 | serotonin metabolic process (GO:0042428) | 2.80478617 |
| 172 | transmission of nerve impulse (GO:0019226) | 2.80028841 |
| 173 | synaptic transmission, dopaminergic (GO:0001963) | 2.79754255 |
| 174 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.78723546 |
| 175 | regulation of regulated secretory pathway (GO:1903305) | 2.78135090 |
| 176 | visual learning (GO:0008542) | 2.77974936 |
| 177 | NIK/NF-kappaB signaling (GO:0038061) | 2.77895148 |
| 178 | regulation of tolerance induction (GO:0002643) | 2.77821502 |
| 179 | regulation of ARF GTPase activity (GO:0032312) | 2.76800409 |
| 180 | neurotransmitter transport (GO:0006836) | 2.76508307 |
| 181 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.75755603 |
| 182 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.75642197 |
| 183 | neuron cell-cell adhesion (GO:0007158) | 2.75060263 |
| 184 | regulation of neurotransmitter levels (GO:0001505) | 2.74935965 |
| 185 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.74894142 |
| 186 | negative regulation of innate immune response (GO:0045824) | 2.74185893 |
| 187 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.74115422 |
| 188 | dopamine receptor signaling pathway (GO:0007212) | 2.73756155 |
| 189 | cellular sodium ion homeostasis (GO:0006883) | 2.72993062 |
| 190 | gamma-aminobutyric acid transport (GO:0015812) | 2.72384559 |
| 191 | * positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.72047047 |
| 192 | positive regulation of type 2 immune response (GO:0002830) | 2.71678627 |
| 193 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.70255477 |
| 194 | positive regulation of interferon-alpha production (GO:0032727) | 2.69245412 |
| 195 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.68820357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.24139571 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.50959618 |
| 3 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.47286287 |
| 4 | * VDR_21846776_ChIP-Seq_THP-1_Human | 3.19185617 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.93879416 |
| 6 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.90552506 |
| 7 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.76537319 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.71951096 |
| 9 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.71591525 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.70981215 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.63412702 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.62517049 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.61000403 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.59594220 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.59329815 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.55552250 |
| 17 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.51338922 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44855985 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.43687790 |
| 20 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40678210 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.39463720 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.38685741 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.36958312 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34329353 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.30332383 |
| 26 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.29471638 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.29084442 |
| 28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.29084442 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28032563 |
| 30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.25516227 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 2.19742508 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.18535775 |
| 33 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.17770975 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.17617259 |
| 35 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.12089188 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.11425991 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 2.09098445 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.07287949 |
| 39 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.03886486 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.02337455 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.00631148 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.00610889 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.98156047 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.91519870 |
| 45 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.84844868 |
| 46 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.84592328 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74603687 |
| 48 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.74408226 |
| 49 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.73021667 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68773978 |
| 51 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.67210216 |
| 52 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.64486097 |
| 53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63854992 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.62569924 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61125173 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60359565 |
| 57 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.60357601 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56888799 |
| 59 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.50682964 |
| 60 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.49876361 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45394951 |
| 62 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.44190104 |
| 63 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.41916783 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.40906096 |
| 65 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.39213781 |
| 66 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.39178679 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37442516 |
| 68 | KDM2B_26808549_Chip-Seq_K562_Human | 1.35134073 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33645646 |
| 70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32934168 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32662825 |
| 72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31463472 |
| 73 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.30198070 |
| 74 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.29750288 |
| 75 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27511591 |
| 76 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27384974 |
| 77 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.27379438 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26928611 |
| 79 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.26735082 |
| 80 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.26475537 |
| 81 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25108411 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24560777 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23801348 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23189881 |
| 85 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.20675335 |
| 86 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19353108 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19281788 |
| 88 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18189264 |
| 89 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.17568480 |
| 90 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16081897 |
| 91 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14665166 |
| 92 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13628837 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.12718588 |
| 94 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12710873 |
| 95 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12599932 |
| 96 | RXR_22108803_ChIP-Seq_LS180_Human | 1.12459532 |
| 97 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.12400886 |
| 98 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12191972 |
| 99 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.11539317 |
| 100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10981066 |
| 101 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10589832 |
| 102 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.08990313 |
| 103 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08416745 |
| 104 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08102800 |
| 105 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.07522770 |
| 106 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06951508 |
| 107 | AR_19668381_ChIP-Seq_PC3_Human | 1.06526093 |
| 108 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05622130 |
| 109 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05607099 |
| 110 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05168102 |
| 111 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04347613 |
| 112 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.03536980 |
| 113 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.03500824 |
| 114 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03048242 |
| 115 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02880096 |
| 116 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02596698 |
| 117 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01852589 |
| 118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01791867 |
| 119 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01721250 |
| 120 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01278546 |
| 121 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99966995 |
| 122 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99144867 |
| 123 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99008239 |
| 124 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.98839697 |
| 125 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98806276 |
| 126 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97625462 |
| 127 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97343414 |
| 128 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96790595 |
| 129 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95461496 |
| 130 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95234187 |
| 131 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.94228603 |
| 132 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.92897710 |
| 133 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.92535897 |
| 134 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.92275826 |
| 135 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92225205 |
| 136 | P68_20966046_ChIP-Seq_HELA_Human | 0.92077747 |
| 137 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91548247 |
| 138 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90542830 |
| 139 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90316862 |
| 140 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.89704185 |
| 141 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89325322 |
| 142 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.89273898 |
| 143 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88993492 |
| 144 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88965365 |
| 145 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88730178 |
| 146 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.88462945 |
| 147 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87806129 |
| 148 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.87762262 |
| 149 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87274497 |
| 150 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.87224988 |
| 151 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87137308 |
| 152 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86971091 |
| 153 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.86258611 |
| 154 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85303256 |
| 155 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85205664 |
| 156 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85137650 |
| 157 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84491343 |
| 158 | MYC_22102868_ChIP-Seq_BL_Human | 0.83842265 |
| 159 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83411103 |
| 160 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.82184220 |
| 161 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.80454405 |
| 162 | TCF4_23295773_ChIP-Seq_U87_Human | 0.80289720 |
| 163 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79411426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 8.18741811 |
| 2 | MP0003880_abnormal_central_pattern | 4.82812528 |
| 3 | MP0002822_catalepsy | 4.26393853 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.20269647 |
| 5 | MP0009745_abnormal_behavioral_response | 3.47956640 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.45176615 |
| 7 | MP0003724_increased_susceptibility_to | 3.24880406 |
| 8 | MP0002064_seizures | 3.06966094 |
| 9 | MP0004270_analgesia | 3.05383575 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.66290715 |
| 11 | MP0001501_abnormal_sleep_pattern | 2.60796869 |
| 12 | MP0009785_altered_susceptibility_to | 2.48921617 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.39092416 |
| 14 | MP0004510_myositis | 2.35354844 |
| 15 | MP0009046_muscle_twitch | 2.22531354 |
| 16 | MP0003075_altered_response_to | 2.16364949 |
| 17 | MP0002272_abnormal_nervous_system | 2.15238549 |
| 18 | MP0001486_abnormal_startle_reflex | 2.11762845 |
| 19 | MP0003329_amyloid_beta_deposits | 1.93582492 |
| 20 | MP0002736_abnormal_nociception_after | 1.93502100 |
| 21 | MP0004947_skin_inflammation | 1.91312732 |
| 22 | MP0010155_abnormal_intestine_physiology | 1.87454807 |
| 23 | MP0002735_abnormal_chemical_nociception | 1.87275832 |
| 24 | MP0008260_abnormal_autophagy | 1.83191401 |
| 25 | MP0005423_abnormal_somatic_nervous | 1.82770480 |
| 26 | MP0002405_respiratory_system_inflammati | 1.81255573 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.81102235 |
| 28 | MP0008569_lethality_at_weaning | 1.79570585 |
| 29 | MP0002396_abnormal_hematopoietic_system | 1.78062488 |
| 30 | MP0001440_abnormal_grooming_behavior | 1.74209441 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.72572674 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.71911641 |
| 33 | MP0002722_abnormal_immune_system | 1.68629757 |
| 34 | MP0003879_abnormal_hair_cell | 1.68181727 |
| 35 | MP0003303_peritoneal_inflammation | 1.66768620 |
| 36 | MP0000569_abnormal_digit_pigmentation | 1.66122453 |
| 37 | * MP0001845_abnormal_inflammatory_respons | 1.64611176 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.64046142 |
| 39 | MP0002429_abnormal_blood_cell | 1.63403033 |
| 40 | MP0004811_abnormal_neuron_physiology | 1.63056351 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.62329167 |
| 42 | MP0002734_abnormal_mechanical_nocicepti | 1.62028926 |
| 43 | MP0003787_abnormal_imprinting | 1.61865850 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.61774071 |
| 45 | MP0003866_abnormal_defecation | 1.60194280 |
| 46 | MP0009278_abnormal_bone_marrow | 1.58180892 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.54635060 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.54606755 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.50442117 |
| 50 | MP0000604_amyloidosis | 1.48750218 |
| 51 | MP0004858_abnormal_nervous_system | 1.47156935 |
| 52 | MP0005451_abnormal_body_composition | 1.46682871 |
| 53 | MP0001970_abnormal_pain_threshold | 1.46415345 |
| 54 | MP0010234_abnormal_vibrissa_follicle | 1.45317862 |
| 55 | MP0003633_abnormal_nervous_system | 1.42791468 |
| 56 | MP0008874_decreased_physiological_sensi | 1.38628337 |
| 57 | MP0005646_abnormal_pituitary_gland | 1.38097043 |
| 58 | MP0002733_abnormal_thermal_nociception | 1.36798132 |
| 59 | MP0005386_behavior/neurological_phenoty | 1.35164928 |
| 60 | MP0004924_abnormal_behavior | 1.35164928 |
| 61 | MP0002067_abnormal_sensory_capabilities | 1.33843859 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.32361461 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.32361461 |
| 64 | MP0005310_abnormal_salivary_gland | 1.30937038 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.29584022 |
| 66 | MP0008961_abnormal_basal_metabolism | 1.28761644 |
| 67 | MP0002557_abnormal_social/conspecific_i | 1.26394454 |
| 68 | MP0004381_abnormal_hair_follicle | 1.24576158 |
| 69 | MP0001851_eye_inflammation | 1.23385284 |
| 70 | MP0008469_abnormal_protein_level | 1.23191162 |
| 71 | MP0005166_decreased_susceptibility_to | 1.16247795 |
| 72 | MP0001835_abnormal_antigen_presentation | 1.13858642 |
| 73 | MP0003183_abnormal_peptide_metabolism | 1.10524047 |
| 74 | MP0008872_abnormal_physiological_respon | 1.10021606 |
| 75 | MP0002066_abnormal_motor_capabilities/c | 1.09813585 |
| 76 | MP0002998_abnormal_bone_remodeling | 1.08978738 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 1.08651871 |
| 78 | MP0001853_heart_inflammation | 1.08530075 |
| 79 | MP0003631_nervous_system_phenotype | 1.08465128 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 1.07192135 |
| 81 | MP0002006_tumorigenesis | 1.06185091 |
| 82 | MP0005535_abnormal_body_temperature | 1.05350152 |
| 83 | MP0000858_altered_metastatic_potential | 1.04377872 |
| 84 | MP0002138_abnormal_hepatobiliary_system | 1.03576320 |
| 85 | MP0003690_abnormal_glial_cell | 1.03029281 |
| 86 | MP0005387_immune_system_phenotype | 1.01019041 |
| 87 | MP0001790_abnormal_immune_system | 1.01019041 |
| 88 | MP0003828_pulmonary_edema | 1.00209716 |
| 89 | MP0001905_abnormal_dopamine_level | 1.00168230 |
| 90 | MP0009764_decreased_sensitivity_to | 0.99789985 |
| 91 | MP0001502_abnormal_circadian_rhythm | 0.99755750 |
| 92 | MP0004885_abnormal_endolymph | 0.99597127 |
| 93 | MP0005671_abnormal_response_to | 0.97601941 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.97052396 |
| 95 | MP0000955_abnormal_spinal_cord | 0.94417857 |
| 96 | MP0001800_abnormal_humoral_immune | 0.94280906 |
| 97 | MP0002184_abnormal_innervation | 0.94072977 |
| 98 | MP0002132_abnormal_respiratory_system | 0.93175329 |
| 99 | MP0005000_abnormal_immune_tolerance | 0.91240203 |
| 100 | MP0002882_abnormal_neuron_morphology | 0.89058702 |
| 101 | MP0002009_preneoplasia | 0.88034169 |
| 102 | MP0001984_abnormal_olfaction | 0.86668809 |
| 103 | MP0005464_abnormal_platelet_physiology | 0.86575620 |
| 104 | MP0000685_abnormal_immune_system | 0.85469565 |
| 105 | MP0002069_abnormal_eating/drinking_beha | 0.85220044 |
| 106 | MP0002723_abnormal_immune_serum | 0.82185727 |
| 107 | MP0003300_gastrointestinal_ulcer | 0.80674636 |
| 108 | MP0000778_abnormal_nervous_system | 0.80460608 |
| 109 | MP0004883_abnormal_blood_vessel | 0.79740839 |
| 110 | MP0005075_abnormal_melanosome_morpholog | 0.78979312 |
| 111 | MP0001348_abnormal_lacrimal_gland | 0.76790741 |
| 112 | * MP0002420_abnormal_adaptive_immunity | 0.76787191 |
| 113 | * MP0001819_abnormal_immune_cell | 0.76159110 |
| 114 | MP0005058_abnormal_lysosome_morphology | 0.75960886 |
| 115 | * MP0002452_abnormal_antigen_presenting | 0.75473744 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.75196599 |
| 117 | MP0000015_abnormal_ear_pigmentation | 0.73186828 |
| 118 | MP0003436_decreased_susceptibility_to | 0.71922047 |
| 119 | MP0001663_abnormal_digestive_system | 0.70637688 |
| 120 | MP0005409_darkened_coat_color | 0.70500485 |
| 121 | MP0009763_increased_sensitivity_to | 0.70204326 |
| 122 | MP0003045_fibrosis | 0.69523977 |
| 123 | MP0003091_abnormal_cell_migration | 0.69191632 |
| 124 | MP0001529_abnormal_vocalization | 0.68940442 |
| 125 | MP0002933_joint_inflammation | 0.66585911 |
| 126 | MP0004130_abnormal_muscle_cell | 0.65419236 |
| 127 | MP0000490_abnormal_crypts_of | 0.64929154 |
| 128 | MP0000920_abnormal_myelination | 0.64522431 |
| 129 | * MP0002419_abnormal_innate_immunity | 0.64211637 |
| 130 | MP0001873_stomach_inflammation | 0.63828347 |
| 131 | * MP0001765_abnormal_ion_homeostasis | 0.63823637 |
| 132 | MP0002152_abnormal_brain_morphology | 0.63635747 |
| 133 | MP0002090_abnormal_vision | 0.63560540 |
| 134 | MP0002398_abnormal_bone_marrow | 0.63409985 |
| 135 | MP0003448_altered_tumor_morphology | 0.62488929 |
| 136 | MP0001177_atelectasis | 0.61837259 |
| 137 | MP0002876_abnormal_thyroid_physiology | 0.61379302 |
| 138 | MP0005645_abnormal_hypothalamus_physiol | 0.60905186 |
| 139 | MP0002148_abnormal_hypersensitivity_rea | 0.59297356 |
| 140 | MP0009840_abnormal_foam_cell | 0.58118546 |
| 141 | MP0000716_abnormal_immune_system | 0.58060860 |
| 142 | MP0002229_neurodegeneration | 0.57001029 |
| 143 | MP0009765_abnormal_xenobiotic_induced | 0.56573794 |
| 144 | MP0008004_abnormal_stomach_pH | 0.55791623 |
| 145 | MP0005025_abnormal_response_to | 0.55360780 |
| 146 | MP0002019_abnormal_tumor_incidence | 0.54971723 |
| 147 | MP0004484_altered_response_of | 0.54080250 |
| 148 | MP0000249_abnormal_blood_vessel | 0.53887289 |
| 149 | MP0003763_abnormal_thymus_physiology | 0.53536623 |
| 150 | MP0005076_abnormal_cell_differentiation | 0.53504251 |
| 151 | MP0006082_CNS_inflammation | 0.52949419 |
| 152 | MP0005174_abnormal_tail_pigmentation | 0.52938218 |
| 153 | MP0002693_abnormal_pancreas_physiology | 0.52374553 |
| 154 | MP0003632_abnormal_nervous_system | 0.51931067 |
| 155 | MP0005164_abnormal_response_to | 0.50738691 |
| 156 | MP0005390_skeleton_phenotype | 0.50031418 |
| 157 | MP0000343_altered_response_to | 0.48385911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.79935702 |
| 2 | Myokymia (HP:0002411) | 7.40244072 |
| 3 | Focal seizures (HP:0007359) | 5.56940789 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.53745381 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.92274652 |
| 6 | Visual hallucinations (HP:0002367) | 4.88800440 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.81988646 |
| 8 | Myositis (HP:0100614) | 4.32002678 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.29942080 |
| 10 | Meningitis (HP:0001287) | 4.23858319 |
| 11 | Epileptic encephalopathy (HP:0200134) | 4.19080248 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.14326031 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.00618603 |
| 14 | Febrile seizures (HP:0002373) | 3.93838873 |
| 15 | Orchitis (HP:0100796) | 3.92457796 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.87385158 |
| 17 | Optic neuritis (HP:0100653) | 3.87385158 |
| 18 | Atonic seizures (HP:0010819) | 3.84027454 |
| 19 | Absence seizures (HP:0002121) | 3.74414148 |
| 20 | Vasculitis (HP:0002633) | 3.72296768 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.68571008 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.67278965 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.67278965 |
| 24 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.63425765 |
| 25 | Recurrent viral infections (HP:0004429) | 3.62231952 |
| 26 | Cellulitis (HP:0100658) | 3.61332517 |
| 27 | Gastrointestinal stroma tumor (HP:0100723) | 3.60887792 |
| 28 | Dialeptic seizures (HP:0011146) | 3.58894080 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.56547501 |
| 30 | Abnormality of the lower motor neuron (HP:0002366) | 3.54882215 |
| 31 | Recurrent skin infections (HP:0001581) | 3.54153233 |
| 32 | Annular pancreas (HP:0001734) | 3.51847705 |
| 33 | Panhypogammaglobulinemia (HP:0003139) | 3.51170985 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.47889348 |
| 35 | Obstructive lung disease (HP:0006536) | 3.47889348 |
| 36 | Papilledema (HP:0001085) | 3.47537773 |
| 37 | Stomatitis (HP:0010280) | 3.47150832 |
| 38 | Supranuclear gaze palsy (HP:0000605) | 3.46689624 |
| 39 | Action tremor (HP:0002345) | 3.40423080 |
| 40 | Encephalitis (HP:0002383) | 3.38765431 |
| 41 | Generalized tonic-clonic seizures (HP:0002069) | 3.38042091 |
| 42 | Colitis (HP:0002583) | 3.37194974 |
| 43 | Gastrointestinal infarctions (HP:0005244) | 3.32273427 |
| 44 | Depression (HP:0000716) | 3.27425449 |
| 45 | Inflammation of the large intestine (HP:0002037) | 3.26157080 |
| 46 | Poor eye contact (HP:0000817) | 3.24624504 |
| 47 | Gastrointestinal inflammation (HP:0004386) | 3.20558809 |
| 48 | Progressive cerebellar ataxia (HP:0002073) | 3.18875621 |
| 49 | Postural instability (HP:0002172) | 3.13674189 |
| 50 | Dysmetria (HP:0001310) | 3.11526202 |
| 51 | Abnormal social behavior (HP:0012433) | 3.06068936 |
| 52 | Impaired social interactions (HP:0000735) | 3.06068936 |
| 53 | Stereotypic behavior (HP:0000733) | 3.02765456 |
| 54 | Urticaria (HP:0001025) | 3.01205793 |
| 55 | Spontaneous hematomas (HP:0007420) | 2.94707916 |
| 56 | Lymphopenia (HP:0001888) | 2.91196507 |
| 57 | Gaze-evoked nystagmus (HP:0000640) | 2.90756110 |
| 58 | Anxiety (HP:0000739) | 2.90569853 |
| 59 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.89082973 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.88744188 |
| 61 | Amblyopia (HP:0000646) | 2.88149595 |
| 62 | Keratoconjunctivitis sicca (HP:0001097) | 2.87018761 |
| 63 | Gingivitis (HP:0000230) | 2.86449019 |
| 64 | Broad-based gait (HP:0002136) | 2.83331555 |
| 65 | Prolonged bleeding time (HP:0003010) | 2.83150223 |
| 66 | Impaired smooth pursuit (HP:0007772) | 2.79461367 |
| 67 | T lymphocytopenia (HP:0005403) | 2.78606099 |
| 68 | Abnormality of T cells (HP:0002843) | 2.76782680 |
| 69 | Truncal ataxia (HP:0002078) | 2.75598925 |
| 70 | Ankle clonus (HP:0011448) | 2.74202912 |
| 71 | Recurrent sinusitis (HP:0011108) | 2.74006067 |
| 72 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.73989663 |
| 73 | Osteomyelitis (HP:0002754) | 2.73474480 |
| 74 | Chest pain (HP:0100749) | 2.71011725 |
| 75 | Abnormality of T cell number (HP:0011839) | 2.70925415 |
| 76 | Pustule (HP:0200039) | 2.70105555 |
| 77 | Dysdiadochokinesis (HP:0002075) | 2.69907692 |
| 78 | Recurrent bronchitis (HP:0002837) | 2.68672841 |
| 79 | Hemiplegia (HP:0002301) | 2.67357138 |
| 80 | Mutism (HP:0002300) | 2.67285624 |
| 81 | Hyperventilation (HP:0002883) | 2.67140411 |
| 82 | Diplopia (HP:0000651) | 2.67073309 |
| 83 | Abnormality of binocular vision (HP:0011514) | 2.67073309 |
| 84 | Torticollis (HP:0000473) | 2.66883780 |
| 85 | Abnormality of T cell physiology (HP:0011840) | 2.66403911 |
| 86 | Abnormal eating behavior (HP:0100738) | 2.65034282 |
| 87 | Dysmetric saccades (HP:0000641) | 2.64616466 |
| 88 | Focal dystonia (HP:0004373) | 2.64285063 |
| 89 | Keratoconjunctivitis (HP:0001096) | 2.61204051 |
| 90 | Urinary urgency (HP:0000012) | 2.61176508 |
| 91 | IgM deficiency (HP:0002850) | 2.57988524 |
| 92 | Hemoptysis (HP:0002105) | 2.56702960 |
| 93 | Bradykinesia (HP:0002067) | 2.55616059 |
| 94 | Pointed chin (HP:0000307) | 2.54445407 |
| 95 | Slow saccadic eye movements (HP:0000514) | 2.50642241 |
| 96 | Impaired vibratory sensation (HP:0002495) | 2.46562585 |
| 97 | Granulocytopenia (HP:0001913) | 2.45202640 |
| 98 | Cerebral inclusion bodies (HP:0100314) | 2.44962501 |
| 99 | Epistaxis (HP:0000421) | 2.42862629 |
| 100 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.41514019 |
| 101 | Autoimmune hemolytic anemia (HP:0001890) | 2.39990090 |
| 102 | Progressive inability to walk (HP:0002505) | 2.38828616 |
| 103 | Hypochromic anemia (HP:0001931) | 2.38783999 |
| 104 | Increased IgM level (HP:0003496) | 2.38246265 |
| 105 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.37410818 |
| 106 | Restrictive lung disease (HP:0002091) | 2.34077519 |
| 107 | Resting tremor (HP:0002322) | 2.33711681 |
| 108 | Viral hepatitis (HP:0006562) | 2.33047811 |
| 109 | Leukocytosis (HP:0001974) | 2.32608150 |
| 110 | Sepsis (HP:0100806) | 2.32376346 |
| 111 | Ankyloglossia (HP:0010296) | 2.31635333 |
| 112 | Abnormality of the periventricular white matter (HP:0002518) | 2.28001234 |
| 113 | Gingival bleeding (HP:0000225) | 2.27705161 |
| 114 | Intention tremor (HP:0002080) | 2.27582812 |
| 115 | Arterial thrombosis (HP:0004420) | 2.25934464 |
| 116 | Pulmonary embolism (HP:0002204) | 2.24598778 |
| 117 | Apathy (HP:0000741) | 2.24114009 |
| 118 | Emphysema (HP:0002097) | 2.23064576 |
| 119 | Craniofacial dystonia (HP:0012179) | 2.21987723 |
| 120 | Petechiae (HP:0000967) | 2.19668636 |
| 121 | Lower limb amyotrophy (HP:0007210) | 2.19253990 |
| 122 | Hypergammaglobulinemia (HP:0010702) | 2.19045507 |
| 123 | Hypochromic microcytic anemia (HP:0004840) | 2.18806113 |
| 124 | Abnormality of the fingertips (HP:0001211) | 2.18543264 |
| 125 | Lower limb asymmetry (HP:0100559) | 2.16084083 |
| 126 | Deep palmar crease (HP:0006191) | 2.15477675 |
| 127 | Neurofibrillary tangles (HP:0002185) | 2.15340904 |
| 128 | Chronic diarrhea (HP:0002028) | 2.14713578 |
| 129 | Scanning speech (HP:0002168) | 2.14643927 |
| 130 | Spastic gait (HP:0002064) | 2.14221271 |
| 131 | Episodic fever (HP:0001954) | 2.13943416 |
| 132 | Bundle branch block (HP:0011710) | 2.13740448 |
| 133 | Skin rash (HP:0000988) | 2.13633469 |
| 134 | Status epilepticus (HP:0002133) | 2.13559711 |
| 135 | Autoimmune thrombocytopenia (HP:0001973) | 2.13252530 |
| 136 | Genetic anticipation (HP:0003743) | 2.10182690 |
| 137 | Drooling (HP:0002307) | 2.08878310 |
| 138 | Excessive salivation (HP:0003781) | 2.08878310 |
| 139 | Abnormality of oral frenula (HP:0000190) | 2.08802425 |
| 140 | Skin ulcer (HP:0200042) | 2.07255224 |
| 141 | Global brain atrophy (HP:0002283) | 2.06792984 |
| 142 | Abnormality of the pleura (HP:0002103) | 2.04649412 |
| 143 | Spinal canal stenosis (HP:0003416) | 2.04177405 |
| 144 | Neuronal loss in central nervous system (HP:0002529) | 2.03335902 |
| 145 | Chronic otitis media (HP:0000389) | 2.02675766 |
| 146 | Diminished motivation (HP:0000745) | 2.01931757 |
| 147 | Recurrent lower respiratory tract infections (HP:0002783) | 1.99347529 |
| 148 | Inappropriate behavior (HP:0000719) | 1.98995240 |
| 149 | Recurrent pneumonia (HP:0006532) | 1.98980084 |
| 150 | Increased IgE level (HP:0003212) | 1.97235235 |
| 151 | Ocular albinism (HP:0001107) | 1.96835054 |
| 152 | Premature loss of primary teeth (HP:0006323) | 1.96167583 |
| 153 | Rapidly progressive (HP:0003678) | 1.95929239 |
| 154 | IgA deficiency (HP:0002720) | 1.95442264 |
| 155 | Abnormality of saccadic eye movements (HP:0000570) | 1.93520760 |
| 156 | Epileptiform EEG discharges (HP:0011182) | 1.92958193 |
| 157 | Gangrene (HP:0100758) | 1.92594353 |
| 158 | Increased cerebral lipofuscin (HP:0011813) | 1.91607111 |
| 159 | Ventricular fibrillation (HP:0001663) | 1.91451381 |
| 160 | Arthralgia (HP:0002829) | 1.88787731 |
| 161 | Amyloidosis (HP:0011034) | 1.87696923 |
| 162 | IgG deficiency (HP:0004315) | 1.87221406 |
| 163 | Eosinophilia (HP:0001880) | 1.86250378 |
| 164 | Psychosis (HP:0000709) | 1.85223681 |
| 165 | Obstructive sleep apnea (HP:0002870) | 1.85111377 |
| 166 | Anorexia (HP:0002039) | 1.84473919 |
| 167 | Polygenic inheritance (HP:0010982) | 1.84431896 |
| 168 | Memory impairment (HP:0002354) | 1.84332055 |
| 169 | Decreased circulating renin level (HP:0003351) | 1.84012225 |
| 170 | Microcytic anemia (HP:0001935) | 1.83995304 |
| 171 | Generalized myoclonic seizures (HP:0002123) | 1.83785275 |
| 172 | Iris hypopigmentation (HP:0007730) | 1.83646818 |
| 173 | Incomplete penetrance (HP:0003829) | 1.83436925 |
| 174 | Rigidity (HP:0002063) | 1.83310688 |
| 175 | Fatigue (HP:0012378) | 1.83222113 |
| 176 | Dementia (HP:0000726) | 1.76009118 |
| 177 | Mediastinal lymphadenopathy (HP:0100721) | 1.75672942 |
| 178 | Verrucae (HP:0200043) | 1.73736163 |
| 179 | Papilloma (HP:0012740) | 1.73736163 |
| 180 | Inability to walk (HP:0002540) | 1.72587337 |
| 181 | Agammaglobulinemia (HP:0004432) | 1.71398072 |
| 182 | Hemiparesis (HP:0001269) | 1.71127692 |
| 183 | Dyskinesia (HP:0100660) | 1.70373301 |
| 184 | Deeply set eye (HP:0000490) | 1.69809642 |
| 185 | Spastic tetraparesis (HP:0001285) | 1.69505790 |
| 186 | EEG with generalized epileptiform discharges (HP:0011198) | 1.67665054 |
| 187 | Insomnia (HP:0100785) | 1.67327868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.76859202 |
| 2 | NTRK3 | 4.67080199 |
| 3 | MAP3K9 | 3.98187722 |
| 4 | RIPK4 | 3.77761632 |
| 5 | MAP3K13 | 3.37445656 |
| 6 | KSR2 | 2.98808429 |
| 7 | DAPK2 | 2.74645680 |
| 8 | ERN1 | 2.48770186 |
| 9 | BLK | 2.44969367 |
| 10 | TYK2 | 2.41691715 |
| 11 | FES | 2.40275748 |
| 12 | ARAF | 2.21321347 |
| 13 | IRAK4 | 2.17359155 |
| 14 | PRKD3 | 2.11927510 |
| 15 | MINK1 | 2.07143842 |
| 16 | DAPK1 | 1.97775490 |
| 17 | CAMKK1 | 1.93943062 |
| 18 | MAP2K3 | 1.92318204 |
| 19 | PRPF4B | 1.90205293 |
| 20 | KSR1 | 1.87429076 |
| 21 | SIK2 | 1.82114900 |
| 22 | BTK | 1.81332834 |
| 23 | CSK | 1.74562769 |
| 24 | PAK6 | 1.69898553 |
| 25 | MAP3K4 | 1.67203712 |
| 26 | MAP3K12 | 1.63041682 |
| 27 | RAF1 | 1.60144409 |
| 28 | ZAP70 | 1.56752792 |
| 29 | MAP3K2 | 1.42816343 |
| 30 | CDK5 | 1.39874054 |
| 31 | MAP4K1 | 1.35937658 |
| 32 | MAP2K7 | 1.35001037 |
| 33 | TAOK3 | 1.33097045 |
| 34 | CSF1R | 1.28440553 |
| 35 | MAP3K11 | 1.26053498 |
| 36 | BMPR2 | 1.25347791 |
| 37 | PRKCH | 1.24402398 |
| 38 | NTRK2 | 1.20940582 |
| 39 | TAOK1 | 1.19098459 |
| 40 | MAP2K4 | 1.18064639 |
| 41 | PDK1 | 1.16769710 |
| 42 | ITK | 1.16432394 |
| 43 | * LYN | 1.15316577 |
| 44 | SMG1 | 1.13502252 |
| 45 | GRK6 | 1.11345804 |
| 46 | CAMK1 | 1.09623358 |
| 47 | NTRK1 | 1.08376971 |
| 48 | STK38 | 1.07777408 |
| 49 | LCK | 1.05687709 |
| 50 | MAP3K1 | 1.03813656 |
| 51 | TNIK | 1.03367209 |
| 52 | MAP3K7 | 1.02350715 |
| 53 | TEC | 0.98663956 |
| 54 | IKBKB | 0.94735381 |
| 55 | PRKCG | 0.92832172 |
| 56 | EPHB1 | 0.92161990 |
| 57 | PLK2 | 0.91900766 |
| 58 | PDPK1 | 0.90406259 |
| 59 | SGK3 | 0.89127955 |
| 60 | GRK5 | 0.87444477 |
| 61 | FGFR3 | 0.87386916 |
| 62 | TYRO3 | 0.87386241 |
| 63 | SIK3 | 0.86688845 |
| 64 | CDK19 | 0.86408238 |
| 65 | MAP3K3 | 0.86226380 |
| 66 | ALK | 0.84851947 |
| 67 | CDK12 | 0.83321458 |
| 68 | FGFR4 | 0.81887032 |
| 69 | TNK2 | 0.80413013 |
| 70 | FGR | 0.78706029 |
| 71 | * SYK | 0.78040848 |
| 72 | JAK1 | 0.77349418 |
| 73 | MATK | 0.77176030 |
| 74 | MARK3 | 0.74181108 |
| 75 | SGK2 | 0.74022413 |
| 76 | HIPK2 | 0.72298537 |
| 77 | STK11 | 0.71048575 |
| 78 | SGK1 | 0.70442666 |
| 79 | RET | 0.70138549 |
| 80 | CAMK2A | 0.69032152 |
| 81 | CAMK2B | 0.68867219 |
| 82 | CAMKK2 | 0.67860178 |
| 83 | MARK2 | 0.63774786 |
| 84 | TESK2 | 0.62846323 |
| 85 | IRAK2 | 0.62586063 |
| 86 | SGK494 | 0.60712462 |
| 87 | SGK223 | 0.60712462 |
| 88 | MAPK11 | 0.60608049 |
| 89 | MOS | 0.60023873 |
| 90 | PIM1 | 0.59238425 |
| 91 | PRKCQ | 0.59021565 |
| 92 | STK10 | 0.58281566 |
| 93 | YES1 | 0.56555245 |
| 94 | DMPK | 0.56137190 |
| 95 | MARK1 | 0.55971489 |
| 96 | TXK | 0.54748940 |
| 97 | CDK18 | 0.54695466 |
| 98 | CAMK4 | 0.54517438 |
| 99 | * HCK | 0.54431702 |
| 100 | MAP3K10 | 0.54110593 |
| 101 | TRIB3 | 0.52880712 |
| 102 | CDK15 | 0.51806440 |
| 103 | PRKD2 | 0.51399146 |
| 104 | MAP2K1 | 0.48999137 |
| 105 | * FYN | 0.48704932 |
| 106 | LRRK2 | 0.45625611 |
| 107 | IKBKE | 0.45349128 |
| 108 | CDK11A | 0.44887532 |
| 109 | RIPK1 | 0.44095920 |
| 110 | NME1 | 0.43997293 |
| 111 | EEF2K | 0.43990931 |
| 112 | CDK14 | 0.43783957 |
| 113 | DAPK3 | 0.42623351 |
| 114 | CAMK1G | 0.42541139 |
| 115 | MAPK4 | 0.42443269 |
| 116 | IRAK1 | 0.41884182 |
| 117 | JAK2 | 0.41415852 |
| 118 | CDK4 | 0.41250722 |
| 119 | MAP2K6 | 0.40641921 |
| 120 | RPS6KA3 | 0.40592143 |
| 121 | SIK1 | 0.39245609 |
| 122 | MAP3K14 | 0.38645452 |
| 123 | WNK1 | 0.37626811 |
| 124 | PINK1 | 0.36216772 |
| 125 | PRKCZ | 0.35824392 |
| 126 | MAP3K5 | 0.34651884 |
| 127 | MAPK10 | 0.34393206 |
| 128 | MAPK13 | 0.34357002 |
| 129 | DYRK1A | 0.34081009 |
| 130 | MAPK12 | 0.33212136 |
| 131 | UHMK1 | 0.33108104 |
| 132 | RPS6KC1 | 0.31894590 |
| 133 | RPS6KL1 | 0.31894590 |
| 134 | MAPK7 | 0.30897290 |
| 135 | LMTK2 | 0.30078013 |
| 136 | PRKCB | 0.28097390 |
| 137 | CLK1 | 0.27955869 |
| 138 | TAOK2 | 0.27698080 |
| 139 | KIT | 0.26944931 |
| 140 | PRKCA | 0.24757999 |
| 141 | JAK3 | 0.24212389 |
| 142 | TBK1 | 0.23755757 |
| 143 | CDC42BPA | 0.23638881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 2.92396866 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 2.90484916 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.88477891 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.81674080 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.70623530 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.64173412 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.58375732 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.57757916 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.47506643 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.35826498 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.28738580 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.21859340 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 2.19231354 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.14329968 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 2.11117226 |
| 16 | Asthma_Homo sapiens_hsa05310 | 2.08929696 |
| 17 | GABAergic synapse_Homo sapiens_hsa04727 | 2.01116231 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.95365049 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.94970790 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.91287093 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.90401548 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.85731503 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81459470 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.72561865 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.70210560 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.67206346 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62735288 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.61610463 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.58791162 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.57188829 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.57066780 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.56897905 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.53081078 |
| 34 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.53045546 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50621786 |
| 36 | Long-term depression_Homo sapiens_hsa04730 | 1.45139046 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.44818961 |
| 38 | Cocaine addiction_Homo sapiens_hsa05030 | 1.43040382 |
| 39 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42378410 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42094703 |
| 41 | Glioma_Homo sapiens_hsa05214 | 1.39242162 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.37202122 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.36009289 |
| 44 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35432029 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32654979 |
| 46 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32144767 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28527285 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27780853 |
| 49 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26180416 |
| 50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.20382128 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19022669 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16608626 |
| 53 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.16089100 |
| 54 | Taste transduction_Homo sapiens_hsa04742 | 1.11484973 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10771583 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10404521 |
| 57 | Malaria_Homo sapiens_hsa05144 | 1.10339909 |
| 58 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.09393870 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07696037 |
| 60 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07448296 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07033257 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05358533 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04364024 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 1.04310396 |
| 65 | Gap junction_Homo sapiens_hsa04540 | 1.03988554 |
| 66 | * Hepatitis B_Homo sapiens_hsa05161 | 1.01449008 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.98713934 |
| 68 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98230930 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97919575 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97046633 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.95009859 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 0.94007406 |
| 73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92375119 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.91768275 |
| 75 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.91565919 |
| 76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90026442 |
| 77 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88916094 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87711069 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87563520 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86834274 |
| 81 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85526620 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84860667 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.84608155 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83129238 |
| 85 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82395818 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80601327 |
| 87 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80287950 |
| 88 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.79827567 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79715232 |
| 90 | Melanogenesis_Homo sapiens_hsa04916 | 0.79553325 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.79331616 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79089897 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75819505 |
| 94 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74793172 |
| 95 | Tuberculosis_Homo sapiens_hsa05152 | 0.73976227 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73873808 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70709669 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70482682 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67980940 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67371314 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66871140 |
| 102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66720855 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66635779 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66508188 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66069496 |
| 106 | Platelet activation_Homo sapiens_hsa04611 | 0.65826547 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63478913 |
| 108 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.63354910 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.61470886 |
| 110 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61420844 |
| 111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60630710 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60286757 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59775180 |
| 114 | Leishmaniasis_Homo sapiens_hsa05140 | 0.59771614 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58189463 |
| 116 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57762718 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56809364 |
| 118 | Axon guidance_Homo sapiens_hsa04360 | 0.56693749 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.55077419 |
| 120 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.54050535 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52739504 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.52301296 |
| 123 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51152379 |
| 124 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50489188 |
| 125 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.50408616 |
| 126 | Lysosome_Homo sapiens_hsa04142 | 0.46228579 |
| 127 | Salmonella infection_Homo sapiens_hsa05132 | 0.46159051 |
| 128 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45805216 |
| 129 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.44882316 |
| 130 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.44717992 |
| 131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44403176 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43775601 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43485286 |
| 134 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43248928 |
| 135 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39949365 |
| 136 | Shigellosis_Homo sapiens_hsa05131 | 0.39945533 |
| 137 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39631141 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39276542 |
| 139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38458130 |
| 140 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.37805912 |
| 141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37276713 |
| 142 | Bile secretion_Homo sapiens_hsa04976 | 0.36738150 |
| 143 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35028732 |
| 144 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34124290 |
| 145 | Pertussis_Homo sapiens_hsa05133 | 0.33373221 |

